{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:51:34Z","timestamp":1791615094549,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infectious vaginitis is one of the most prevalent conditions affecting women of reproductive age with significant clinical consequences. Bacterial vaginosis (BV), vulvo-vaginal candidiasis (VVC), and trichomoniasis (TV) are the main etiologies. Unfortunately, there is limited data on the prevalence and associated risk factors, especially in sub-saharan Africa. This study, thus, determined the prevalence and risk factors of infectious vaginitis among women seeking reproductive health services at a Marie-stopes health facility in urban areas of Kampala, Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study with 361 participants was conducted from July to October 2021. Data on risk factors and infection were collected via a structured questionnaire and laboratory analysis of vaginal swabs, respectively, with data analysis performed using Stata version 14.0 college station, Texas 77,845 US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ages of participants ranged from 18 to 49 years, with a mean age of 29.53 years. Overall, 58.45% were infected, of whom 33.24% had VVC, 24.93% had BV, and 0.28% had TV. Bivariate analysis revealed that women with pruritus (COR: 3.057, 95% CI: 1.940\u20134.819), pregnancy (COR: 4.914, 95% CI: 1.248\u201319.36), antibiotic use (COR: 1.592, 95% CI: 1.016\u20132.494), douching (COR: 1.719, 95% CI: 1.079\u20132.740), and multiple partners (COR: 1.844, 95% CI: 1.079\u20132.904) were more likely to have VVC, whereas having higher education status (University; Vocational) (COR: 0.325, 95% CI: 0.134\u20130.890; COR: 0.345, 95% CI: 0.116\u20130.905) reduced the risk. On the other hand, women with a smelly discharge (COR: 1.796, 95% CI: 1.036\u20133.110), IUD use (COR: 1.868, 95% CI: 1.039\u20133.358), and antibiotic use (COR: 1.731, 95% CI: 1.066\u20132.811) were more likely to have BV. Multivariable analysis identified pruritus (AOR: 2.861, 95% CI: 1.684\u20134.863) as the only independent predictor for VVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Results indicate a high prevalence of infection among these women; therefore regular screening and treatment is recommended to curb the high rate of infection. More studies on risk factors of infection are recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02835-w","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T03:03:09Z","timestamp":1702954989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Infectious vaginitis among women seeking reproductive health services at a sexual and reproductive health facility in Kampala, Uganda"],"prefix":"10.1186","volume":"23","author":[{"given":"Huzaima","family":"Mujuzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggrey","family":"Siya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogers","family":"Wambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"2835_CR1","doi-asserted-by":"crossref","unstructured":"Mulu W, Yimer M, Zenebe Y, Abera B. Common causes of vaginal Infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot Referral Hospital, Ethiopia : a cross sectional study. 2015;:1\u20139.","DOI":"10.1186\/s12905-015-0197-y"},{"key":"2835_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/817092","volume":"2015","author":"A Narayankhedkar","year":"2015","unstructured":"Narayankhedkar A, Hodiwala A, Mane A. Clinicoetiological characterization of infectious vaginitis amongst women of Reproductive Age Group from Navi Mumbai, India. J Sex Transm Dis. 2015;2015:1\u20135.","journal-title":"J Sex Transm Dis"},{"key":"2835_CR3","first-page":"762","volume":"7","author":"S Shaikh","year":"2018","unstructured":"Shaikh S, Waghmare P, Sharma A, Ingole K, Bawane R. A retrospective evaluation of Vaginitis in Women of Reproductive Age Group in a Tertiary Care Hospital in Solapur. India. 2018;7:762\u20138.","journal-title":"India"},{"key":"2835_CR4","doi-asserted-by":"crossref","unstructured":"Sianou A, Galyfos G, Moragianni D, Baka S. Prevalence of vaginitis in different age groups among females in Greece. 2017;3615 May.","DOI":"10.1080\/01443615.2017.1308322"},{"key":"2835_CR5","first-page":"1","volume":"3","author":"M Abdul-aziz","year":"2019","unstructured":"Abdul-aziz M, Mahdy MAK, Abdul-ghani R, Alhilali NA, Al-mujahed LKA, Alabsi SA, et al. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana \u2019 a city. Yemen. 2019;3:1\u201310.","journal-title":"Yemen"},{"key":"2835_CR6","unstructured":"Tempera G. Vaginal infections: epidemiology and risk factors. 2005;XXVII."},{"key":"2835_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-5-12","volume":"5","author":"E Demba","year":"2005","unstructured":"Demba E, Morison L, van der Loeff MS, Awasana AA, Gooding E, Bailey R, et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in the Gambia, West Africa. BMC Infect Dis. 2005;5:1\u201312.","journal-title":"BMC Infect Dis"},{"key":"2835_CR8","doi-asserted-by":"crossref","unstructured":"Shahinfar S, Nemanpour B. The Relationship Between Contraceptive Methods and Common Vaginal Infections. 2017;4:2\u20137.","DOI":"10.17795\/whb.40793"},{"key":"2835_CR9","unstructured":"Felipe J, Mart\u00ednez Z, Mu\u00f1oz AP, Felipe A, Ot\u00e1lvaro T, Gonz\u00e1lez JD et al. Risk factors associated to vaginal Infections and squamous intraepithelial lesions in university students in Medell\u00edn, Colombia Factores De Riesgo asociados a infecciones vaginales y lesiones escamosas intraepiteliales en estudiantes universitarias de Me. 2018;:97\u2013106."},{"key":"2835_CR10","doi-asserted-by":"crossref","unstructured":"Vieira-baptista P, Bornstein J, Candidiasis. Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva Pedro. 2019.","DOI":"10.1007\/978-3-319-61621-6_24"},{"key":"2835_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-018-0607-z","volume":"18","author":"A Bitew","year":"2018","unstructured":"Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18:1\u201310.","journal-title":"BMC Womens Health"},{"key":"2835_CR12","unstructured":"Demb\u00e9l\u00e9 R, Kagambega AB, Aim\u00e9 W, Kabor\u00e9 D, Traor\u00e9 O, Nezien D et al. iMedPub journals prevalence and characterization of bacterial and Yeast Vaginal Infections in a Public Health Institution of Ouagadougou. Burkina Faso. 2021;:1\u20136."},{"key":"2835_CR13","doi-asserted-by":"crossref","unstructured":"Payne VK, Florence C\u00e9cile TT, Cedric Y, Christelle Nadia NA, Jos\u00e9 O. Risk Factors Associated with Prevalence of Candida albicans, Gardnerella vaginalis, and Trichomonas vaginalis among Women at the District Hospital of Dschang, West Region, Cameroon. Int J Microbiol. 2020;2020.","DOI":"10.1155\/2020\/8841709"},{"key":"2835_CR14","doi-asserted-by":"crossref","unstructured":"Olowe OA, Makanjuola OB, Olowe R, Adekanle DA. Prevalance of Vulvovaginal Candidiasis, Trichomoniasis and bacterial vaginosis among pregnant women receiveng antenatal care in southwestern Nigeria. 2014;4:193\u20137.","DOI":"10.1556\/EUJMI-D-14-00027"},{"key":"2835_CR15","doi-asserted-by":"crossref","unstructured":"Konadu DG, Owusu-ofori A, Yidana Z, Boadu F, Iddrisu LF, Adu-gyasi D et al. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. 2019;:1\u201310.","DOI":"10.1186\/s12884-019-2488-z"},{"key":"2835_CR16","doi-asserted-by":"crossref","unstructured":"Paxton LA, Sewankambo N, Gray R, Serwadda D, Mcnairn D, Li C et al. Asymptomatic non-ulcerative genital tract Infections in a rural Ugandan population. 1998;:421\u20135.","DOI":"10.1136\/sti.74.6.421"},{"key":"2835_CR17","doi-asserted-by":"crossref","unstructured":"Tann CJ, Mpairwe H, Morison L, Nassimu K, Hughes P, Omara M et al. Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. 2006;:285\u201390.","DOI":"10.1136\/sti.2005.014845"},{"key":"2835_CR18","unstructured":"Kish L. Survey sampling. 1965; Systematic Biology:643."},{"key":"2835_CR19","doi-asserted-by":"crossref","unstructured":"Neugent P, Robert. Marijane A Krohn SLH. Reliability of diagnosing bacterial vaginosis is improved by standardized method of Gram Stain Interpretation a. 1991;29:297\u2013301.","DOI":"10.1128\/jcm.29.2.297-301.1991"},{"key":"2835_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/jcp.29.2.154","volume":"29","author":"PR Mason","year":"1976","unstructured":"Mason PR, Heather Super, Fripp PJ. Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis Infection. J Clin Pathol. 1976;29:154\u20137.","journal-title":"J Clin Pathol"},{"key":"2835_CR21","unstructured":"Dipak Bhargava* S, Kar, Abhilasha Saha MS. Indian Journal of Medical Research and Pharmaceutical sciences prevalance of vaginitis in females attending National medical college and teaching hospital, Birgunj, Nepal. Indian J Med Res Pharm Sci. 2016;3:39\u201343."},{"key":"2835_CR22","doi-asserted-by":"crossref","unstructured":"Elizabeth R, Mascarenhas M, Machado C, Fernando B, Fernandes R, Pimentel W et al. Prevalence and Risk Factors for Bacterial Vaginosis and Other Vulvovaginitis in a Population of Sexually Active Adolescents from Salvador, Bahia, Brazil. 2012;2012.","DOI":"10.1155\/2012\/378640"},{"key":"2835_CR23","doi-asserted-by":"crossref","unstructured":"Abdullahi Nasir I, Uchenna E, Onyia J, Ifunanya AL. Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Res Rep Trop Med. 2015;:37.","DOI":"10.2147\/RRTM.S82984"},{"issue":"2 February","key":"2835_CR24","first-page":"1","volume":"17","author":"GT Yalew","year":"2022","unstructured":"Yalew GT, Muthupandian S, Hagos K, Negash L, Venkatraman G, Hagos YM, et al. Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: a cross-sectional study. PLoS ONE. 2022;17(2 February):1\u201321.","journal-title":"PLoS ONE"},{"key":"2835_CR25","doi-asserted-by":"crossref","unstructured":"Ibrahim SM, Bukar M, Galadima GB, Audu BM, Ibrahim HA. Prevalance of bacterial vaginosis in preganant women in Maiduguri, North Eastern Nigeria. Niger J Clical Pract. 2014;:154\u20138.","DOI":"10.4103\/1119-3077.127424"},{"key":"2835_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-008530","volume":"5","author":"MJ Redelinghuys","year":"2015","unstructured":"Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard H, Olorunju SAS, Kock MM. A cross-sectional study on the relationship of age, gestational age and HIV Infection to bacterial vaginosis and genital mycoplasma Infection. BMJ Open. 2015;5:1\u20137.","journal-title":"BMJ Open"},{"key":"2835_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1186\/1756-0500-7-822","volume":"7","author":"Z Mengistie","year":"2014","unstructured":"Mengistie Z, Woldeamanuel Y, Asrat D. Prevalence of bacterial vaginosis among pregnant women attending antenatal care in Tikur Anbessa University Hospital, Addis Ababa, Ethiopia. BMC Res Notes. 2014;7:822.","journal-title":"BMC Res Notes"},{"key":"2835_CR28","first-page":"198","volume":"24","author":"S Ayenalem","year":"2010","unstructured":"Ayenalem S, Yusuf L, Ashenafi M. Lactic acid bacterial vaginosis among outpatients in Addis Ababa. Ethiop J Heal Dev. 2010;24:198\u2013204.","journal-title":"Ethiop J Heal Dev"},{"key":"2835_CR29","doi-asserted-by":"crossref","unstructured":"Bitew A, Abebaw Y, Bekele D, Mihret A. Prevalence of bacterial vaginosis and associated risk factors among women complaining of genital tract infection. Int J Microbiol. 2017;2017 ii.","DOI":"10.1155\/2017\/4919404"},{"key":"2835_CR30","doi-asserted-by":"crossref","unstructured":"Francis SC, Looker C, Vandepitte J, Bukenya J, Mayanja Y, Nakubulwa S et al. Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment. 2016;:142\u20138.","DOI":"10.1136\/sextrans-2015-052160"},{"key":"2835_CR31","doi-asserted-by":"crossref","unstructured":"Dahal P, Jhendi S, Pun CM, Maharjan L. Assessment of Risk Factors and Medication Use for Infectious Vaginitis Among Females of Reproductive Age Visiting Maternity Hospital of Pokhara, Nepal. 2017;:140\u20137.","DOI":"10.2174\/1874944501710010140"},{"key":"2835_CR32","unstructured":"CDC. Vulvovaginal Candidiasis \u2013\u20092015 STD Treatment Guidelines. 2015. https:\/\/www.cdc.gov\/std\/tg2015\/candidiasis.htm. Accessed 27 May 2021."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02835-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:02:59Z","timestamp":1702998179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02835-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02835-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3108068\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"25 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study obtained ethical approval from ethics committee of Mulago National Referral Hospital Research and Ethics Committee, number MHREC 2256. Written Informed consent was taken from all participants before participating in this study. All methods were performed in accordance with the relevant guidelines and regulations of the Helsinki declaration of medical research ethics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}